Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
Subscribe To Our Newsletter & Stay Updated
